{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:59:34Z","timestamp":1779379174347,"version":"3.53.1"},"reference-count":40,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["biom rep"],"DOI":"10.3892\/br.2019.1189","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T09:16:21Z","timestamp":1549271781000},"source":"Crossref","is-referenced-by-count":4,"title":["Changes in serum LDL, PCSK9 and microRNA\u2011122 in patients with chronic HCV infection receiving Daclatasvir\/Asunaprevir"],"prefix":"10.3892","author":[{"given":"Tatsuki","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850\u20118555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisamitsu","family":"Miyaaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852\u20118523, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Miuma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852\u20118523, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naota","family":"Taura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852\u20118523, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Motoyoshi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850\u20118555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Akahoshi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850\u20118555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Innovation and Translational Research Center, Nagasaki Harbor Medical Center, Nagasaki 850\u20118555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youichi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Innovation and Translational Research Center, Nagasaki Harbor Medical Center, Nagasaki 850\u20118555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsurou","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850\u20118555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yajima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850\u20118555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryouhei","family":"Uehara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850\u20118555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Hino","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Community Care Systems, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852\u20118523, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syouhei","family":"Narita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850\u20118555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisaya","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850\u20118555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seina","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850\u20118555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852\u20118523, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"key20200712183912_b1-br-0-0-1189","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/gut.2009.192732","article-title":"Abnormalities of lipid metabolism in hepatitis C virus infection","volume":"59","author":"Negro","year":"2010","journal-title":"Gut"},{"key":"key20200712183912_b2-br-0-0-1189","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2049936115585942","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"3","author":"Cacoub","year":"2016","journal-title":"Ther Adv Infect Dis"},{"key":"key20200712183912_b3-br-0-0-1189","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4254\/wjh.v7.i3.327","article-title":"Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer","volume":"7","author":"Ferri","year":"2015","journal-title":"World J Hepatol"},{"key":"key20200712183912_b4-br-0-0-1189","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tem.2009.07.005","article-title":"Hepatitis C virus hijacks host lipid metabolism","volume":"21","author":"Syed","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"key20200712183912_b5-br-0-0-1189","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/hep.24724","article-title":"Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders","volume":"55","author":"Chayama","year":"2012","journal-title":"Hepatology"},{"key":"key20200712183912_b6-br-0-0-1189","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/jgh.13587","article-title":"Effectiveness and safety of daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: Systematic review and meta-analysis","volume":"32","author":"Wang","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"e104783","key":"key20200712183912_b7-br-0-0-1189","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104783","article-title":"Distinct patterns of the lipid alterations between genotype 1 and 2 chronic hepatitis C patients after viral clearance","volume":"9","author":"Chang","year":"2014","journal-title":"PLoS One"},{"key":"key20200712183912_b8-br-0-0-1189","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jhep.2015.08.027","article-title":"Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin","volume":"64","author":"Younossi","year":"2016","journal-title":"J Hepatol"},{"key":"key20200712183912_b9-br-0-0-1189","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/hep.27424","article-title":"Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients","volume":"61","author":"Meissner","year":"2015","journal-title":"Hepatology"},{"issue":"e0163644","key":"key20200712183912_b10-br-0-0-1189","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163644","article-title":"Rapid increase in serum low-density lipoprotein cholesterol concentration during hepatitis C interferon-free treatment","volume":"11","author":"Hashimoto","year":"2016","journal-title":"PLoS One"},{"key":"key20200712183912_b11-br-0-0-1189","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N Engl J Med"},{"key":"key20200712183912_b12-br-0-0-1189","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab"},{"key":"key20200712183912_b13-br-0-0-1189","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1111\/liv.12429","article-title":"Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease","volume":"34","author":"Miyaaki","year":"2013","journal-title":"Liver Int"},{"key":"key20200712183912_b14-br-0-0-1189","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nsmb1235","article-title":"Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia","volume":"14","author":"Cunningham","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"key20200712183912_b15-br-0-0-1189","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/hep.22911","article-title":"PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression","volume":"50","author":"Labont\u00e9","year":"2009","journal-title":"Hepatology"},{"key":"key20200712183912_b16-br-0-0-1189","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1128\/JVI.02727-13","article-title":"Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation","volume":"88","author":"Syed","year":"2014","journal-title":"J Virol"},{"key":"key20200712183912_b17-br-0-0-1189","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jhep.2014.11.016","article-title":"PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolism","volume":"62","author":"Bridge","year":"2015","journal-title":"J Hepatol"},{"key":"key20200712183912_b18-br-0-0-1189","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"key20200712183912_b19-br-0-0-1189","doi-asserted-by":"publisher","first-page":"759","DOI":"10.11213\/tonyobyo.51.759","article-title":"Indices of urinary and serum C-peptide corrected with fasting plasma glucose for decision-making of insulin therapy in type 2 diabetes-validation and comparison","volume":"51","author":"Asano","year":"2008","journal-title":"J Jpn Diabetes Soc"},{"key":"key20200712183912_b20-br-0-0-1189","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1001\/jama.1986.03380170088024","article-title":"A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study","volume":"256","author":"DeLong","year":"1986","journal-title":"JAMA"},{"key":"key20200712183912_b21-br-0-0-1189","doi-asserted-by":"publisher","first-page":"E41","DOI":"10.1210\/jc.2014-3066","article-title":"Removal of plasma mature and furin-cleaved proprotein convertase subtilisin\/kexin 9 by low-density lipoprotein-apheresis in familial hypercholesterolemia: Development and application of a new assay for PCSK9","volume":"100","author":"Hori","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"key20200712183912_b22-br-0-0-1189","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"e184","key":"key20200712183912_b23-br-0-0-1189","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2015.68","article-title":"Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma","volume":"47","author":"Sohn","year":"2015","journal-title":"Exp Mol Med"},{"key":"key20200712183912_b24-br-0-0-1189","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1478-3231.2008.01950.x","article-title":"Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data","volume":"29 (Suppl 2)","author":"Negro","year":"2009","journal-title":"Liver Int"},{"key":"key20200712183912_b25-br-0-0-1189","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.atherosclerosis.2016.01.025","article-title":"microRNAs in lipoprotein metabolism and cardiometabolic disorders","volume":"246","author":"Rotllan","year":"2016","journal-title":"Atherosclerosis"},{"key":"key20200712183912_b26-br-0-0-1189","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science"},{"key":"key20200712183912_b27-br-0-0-1189","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/hepr.12317","article-title":"Significance of miRNA-122 in chronic hepatitis C patients with serotype 1 on interferon therapy","volume":"45","author":"Kamo","year":"2015","journal-title":"Hepatol Res"},{"key":"key20200712183912_b28-br-0-0-1189","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1073\/pnas.1012464108","article-title":"Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex","volume":"108","author":"Machlin","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20200712183912_b29-br-0-0-1189","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1073\/pnas.1112263109","article-title":"Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex","volume":"109","author":"Shimakami","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20200712183912_b30-br-0-0-1189","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nature06205","article-title":"Interferon modulation of cellular microRNAs as an antiviral mechanism","volume":"449","author":"Pedersen","year":"2007","journal-title":"Nature"},{"key":"key20200712183912_b31-br-0-0-1189","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nm.1902","article-title":"Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy","volume":"15","author":"Sarasin-Filipowicz","year":"2009","journal-title":"Nat Med"},{"key":"key20200712183912_b32-br-0-0-1189","doi-asserted-by":"crossref","first-page":"30561","DOI":"10.1074\/jbc.M606495200","article-title":"The proprotein convertase (PC) PCSK9 is inactivated by furin and\/or PC5\/6A: Functional consequences of natural mutations and post-translational modifications","volume":"281","author":"Benjannet","year":"2006","journal-title":"J Biol Chem"},{"key":"key20200712183912_b33-br-0-0-1189","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/MOL.0000000000000114","article-title":"PCSK9 and LDLR degradation: Regulatory mechanisms in circulation and in cells","volume":"25","author":"Lagace","year":"2014","journal-title":"Curr Opin Lipidol"},{"issue":"107","key":"key20200712183912_b34-br-0-0-1189","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-016-0428-z","article-title":"Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases","volume":"15","author":"Girona","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"key20200712183912_b35-br-0-0-1189","first-page":"1135","article-title":"Correlation of serum PCSK9 in CHD patients with the severity of coronary arterial lesions","volume":"20","author":"Wang","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20200712183912_b36-br-0-0-1189","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/07853890.2016.1188328","article-title":"Liver fat accumulation is associated with circulating PCSK9","volume":"48","author":"Ruscica","year":"2016","journal-title":"Ann Med"},{"key":"key20200712183912_b37-br-0-0-1189","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.metabol.2009.09.009","article-title":"Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a useful marker for early-stage carotid atherosclerosis","volume":"59","author":"Tamada","year":"2010","journal-title":"Metabolism"},{"key":"key20200712183912_b38-br-0-0-1189","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00535-012-0610-3","article-title":"Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: A population-based study in an HCV hyperendemic area","volume":"48","author":"Miyajima","year":"2013","journal-title":"J Gastroenterol"},{"key":"key20200712183912_b39-br-0-0-1189","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.jhep.2014.08.003","article-title":"Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases","volume":"61 (Suppl 1)","author":"Negro","year":"2014","journal-title":"J Hepatol"},{"issue":"137","key":"key20200712183912_b40-br-0-0-1189","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-015-0143-x","article-title":"Correlation between small dense low-density lipoprotein cholesterol and carotid artery intima-media thickness in a healthy Chinese population","volume":"14","author":"Shen","year":"2015","journal-title":"Lipids Health Dis"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T17:39:20Z","timestamp":1594575560000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2019.1189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":40,"URL":"https:\/\/doi.org\/10.3892\/br.2019.1189","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]}}}